Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gastro One is a private U.S. gastroenterology practice serving the greater Memphis region, with clinic locations in Tennessee and Mississippi and affiliated endoscopy centers. The organization provides diagnosis, treatment, and procedural care for a broad range of digestive, liver, pancreatic, and colorectal conditions, including reflux disease, inflammatory bowel disease, pancreatitis, celiac disease, liver disease, and GI cancers. It also offers screening and interventional services such as colonoscopy and Barrett's esophagus screening/ablation, and has adopted technologies including GI Genius AI-assisted colonoscopy. Gastro One appears to operate as a physician-led specialty care provider rather than a drug-development biotech or pharma company, though it also participates in clinical research and disease-focused care programs such as IBD One and OneWeigh.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gastro One.